Patient Controlled Injectors Market

Patient-Controlled Injectors Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

  • Ongoing
  • February 2020
  • REP-GB-9301
  • PDF PPT EXCEL
Patient Controlled Injectors Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This Patient Controlled Injectors market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Patient Controlled Injectors market.


Patient-Controlled Injectors: Market Insights

With the advent of drug delivery system, new technologies have evolved for betterment of patient ease and comfort aiding patient compliance, safety and adherence. Recent innovations such as patient-controlled injectors is booming the market and thus many companies focus on developing patient controlled delivering systems and wearable injectors. Patient-controlled injectors spur an important innovations in injectable administration of drugs. Ergonomically developed and design patient-controlled injectors can help in optimizing self-care making it easy for patients to hold the system and administer the dosages at just one press. Patient-controlled injectors enables the patient to control the dosage rate by their own which as a result reduces the pain unlike spring-based auto-injectors. Thus new development in science and technology has made new innovation for greater ease and comfort for patients.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Need granular data and specific insights that are hard to get?

Patient-Controlled Injectors: Market Dynamics

Patient-controlled injectors is expected to grow simultaneously in the market owing to greater ease and comfort for administration of injections which as a result will gain significant popularity among people. In addition to this, controlled release of the patient-controlled injectors helps the patient to administration the injection by own and helps them to decide their own dosage rate. All these factors may drive the global patient-controlled injectors market. Besides, the patient-controlled injectors can be administered at home settings and thus there occurs increase in demand of the patient-controlled injectors. Many manufacturers are now focused on developing patient-controlled injectors to meet the unmet needs and so the patient-controlled injectors is stimulating the growth of the market. However, lack of awareness about the patient-controlled injectors may hamper the growth of the market.

Patient-Controlled Injectors Market: Overview

Patient-controlled injectors is the latest innovation in administration of injections. There occurs high unmet needs of patients requiring the patient-controlled injectors as it has greater ease and comfort as compared to spring-based auto-injectors. For example, in 2019, Janseen has received FDA approval of Tremfya one-press patient-controlled Injector for the treatment of patient with Plaque Psoriasis. One-Press is design to help the patient to control the pressure and the rate of the injection. Apart from this, West Pharmaceutical Services, Inc has also developed self-dose patient-controlled injectors which provide an off-the-shelf delivery system which is optimally design for drug administration in patients. Self-dose patient-controlled injectors is designed with a prefilled 1ml syringe with a system of passive needle safety. Thus with the latest innovation in injections, patient-controlled injectors is likely to anticipate the growth of the market in coming years.

Patient-Controlled Injectors: Region-wise Outlook

On the basis of geography, the global patient-controlled injectors market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa. North America is projected to hold the substantial share in the patient-controlled injectors market due to increasing adoption of new technologies and rising healthcare expenditure. Europe market spur to have high growth in patient-controlled injectors market due to advancement in technology and adoption of new devices. Asia Pacific is also potentially stimulating the growth of the patient-controlled injectors market due to increasing awareness among people and demand for new treatment options. Japan has the potential to grow the overall patient-controlled injectors market due to increasing healthcare infrastructure and innovation in technologies. Middle East & Africa have less impact in overall patient-controlled injectors market due to lack of proper healthcare infrastructure and lack of awareness about new treatment may hamper the patient-controlled injectors market.

Patient-Controlled Injectors Market: Key Players

Some of the key players present across the value chain of the global patient-controlled injectors market are West Pharmaceutical Services, Inc, Janssen Pharmaceutical, Westbourne Medical Ltd.

The report covers exhaustive analysis on:

  • Market Segments
  • Market Dynamics
  • Market Size
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Value Chain

The regional analysis includes:

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
  • Eastern Europe (Poland, Russia)
  • Asia-Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • The Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key Patient Controlled Injectors Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Patient-Controlled Injectors Market: Segmentation

The global patient-controlled injectors market is segmented by distributional channel.

Segmentation by Distributional Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields
Our Clients

Request Sample Request customization Request Methodology